clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Update Preferences
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
Molecular Dx
Intense Ultrasound Releases Cancer Biomarkers, Allows for Earlier Cancer Detection
Molecular Dx
Genetic Variant Linked to Cardiovascular Disease and Death in Black Americans
News & Features
Takeda Signs Deal Worth $2.2 Billion with AC Immune for Alzheimer’s…
News & Features
Ultra-Low Energy MRI Shows Its Potential
News & Features
Personal Vaccine Combined with Immune-Boosting Agent Improves Treatment of Malignant Glioma
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Inside Precision Medicine
Zenas Nets $200M to Advance mAb for Autoimmune Diseases
Healthcare financing
News & Features
Zenas Nets $200M to Advance mAb for Autoimmune Diseases
Malorye Branca
-
May 9, 2024
0
News & Features
Patients of New Doctors with High Board Certification Scores Have Higher Survival Rates
Chris Anderson
-
May 8, 2024
0
News & Features
Metsera Launches with $290M to Develop Next Generation Weight Loss Products
Malorye Branca
-
April 22, 2024
0
News & Features
Major Changes Needed in How Patients with Comorbidities Are Chosen for Lung Cancer Screening
Chris Anderson
-
March 26, 2024
0
News & Features
Depression and Anxiety Treatment for People with Heart Disease Decreases ER Visits
Chris Anderson
-
March 20, 2024
0
News & Features
Mailed Outreach Doubles Hepatocellular Carcinoma (HCC) Surveillance Imaging Uptake
Chris Anderson
-
January 3, 2024
0
News & Features
Focusing on Women’s Health
Kathy Vuksanaj
-
December 21, 2023
0
Molecular Dx
Grail Launches Medicare Multi-Cancer Early Detection Study
Chris Anderson
-
November 22, 2023
0
News & Features
Basics of Cancer Care Lacking at Hospitals Serving Black and Hispanic Patients
Camille Mojica Rey, Ph.D.
-
November 22, 2023
0
News & Features
Framework Improves Machine-Learning Model Predictions
Anita Chakraverty
-
November 10, 2023
0
1
2
3
...
13
Page 1 of 13
Related Content
New Evidence of X-Chromosome’s Role in Autoimmune Disease in Women
Enlaza Nets $100M to Advance Covalent Biologics Platform
The Human Immunome Project Plans to Unlock the Immune System’s Secrets
Metsera Launches with $290M to Develop Next Generation Weight Loss Products
Inside Precision Medicine
![Genomenon said today it has partnered with Rhythm Pharmaceuticals to create a database of genetic mutations associated with obesity as documented in published studies. Rhythm plans to use the data to better understand rare genetic disorders of obesity. [Visual Mozart/Getty Images]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/1628-768x794.jpeg "Metsera Launches with $290M to Develop Next Generation Weight Loss Products")
